Prot# CMO-US-GI-0429: A Phase 4 Multicenter, Multinational, Prospective, Randomized, Placebo-Controlled, Double-Blinded Parallel Group Study to Assess Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Patients W

Project: Research project

Project Details

StatusFinished
Effective start/end date8/25/175/31/19

Funding

  • INC Research, LLC (Prot# CMO-US-GI-0429)
  • Allergan Sales, LLC (Prot# CMO-US-GI-0429)